Elixir Drugs Private Limited
Founded in 2008 and headquartered in Uttar Pradesh, India.
2008 | Meerut, Uttar Pradesh (India) | Active
Elixir Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -4.39%
- Profit Growth -5.08%
- Ebitda 23.58%
- Net Worth 6.23%
- Total Assets 5.64%
About Elixir Drugs
Elixir Drugs Private Limited (EDPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 April 2008 and has a history of 16 years and 11 months. Its registered office is in Meerut, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Saxena and Anupma Saxena serve as directors at the Company.
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24233UP2008PTC034961
- Company No.
034961
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Healthcare
Elixir Drugs Private Limited
Explore comprehensive data for Elixir Drugs Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Elixir Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Saxena  | Director | 08-Apr-2008 | Current |
| Anupma Saxena | Director | 01-Nov-2011 | Current |
Financial Performance of Elixir Drugs.
Elixir Drugs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.39% decrease. The company also saw a slight decrease in profitability, with a 5.08% decrease in profit. The company's net worth moved up by a moderate rise of 6.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elixir Drugs?
Unlock access to Elixir Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Elixir Drugs?
Unlock and access historical data on people associated with Elixir Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elixir Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixir Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Elixir Drugs
Recent activity within the organization
- Annual General Meeting
Elixir Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Elixir Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
- Director Appointment
Anupma Saxena was appointed as a Director was appointed as a Director on 01 Nov 2011 & has been associated with this company since 13 years 4 months .
- Director Appointment
Sanjay Saxena was appointed as a Director was appointed as a Director on 08 Apr 2008 & has been associated with this company since 16 years 11 months .
- Company Incorporation
Elixir Drugs Private Limited was registered on 08 Apr 2008 with Roc Kanpur & aged 16 years 11 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Elixir Drugs Private Limited?
Elixir Drugs Private Limited was incorporated on 08 Apr 2008.
What is authorized share capital and paid-up capital of Elixir Drugs Private Limited?
The authorized share capital of Elixir Drugs Private Limited is ₹ 0.30 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Elixir Drugs Private Limited?
Currently 2 directors are associated with Elixir Drugs Private Limited.
- Sanjay Saxena
- Anupma Saxena
What is the registered address of Elixir Drugs Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Elixir Drugs Private Limited is 138, New Hanuman Puri Suraj Kund Road India, Meerut, Uttar Pradesh, 250002.
What is the corporate identification number (CIN) and company number of Elixir Drugs Private Limited?
The corporate identification number (CIN) of Elixir Drugs Private Limited is U24233UP2008PTC034961 and the company number is 034961 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Elixir Drugs Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Elixir Drugs Private Limited has fallen by -4.39%.
What change has been observed in the net worth of Elixir Drugs Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Elixir Drugs Private Limited has experienced an upsurge of 6.23%.
When was the last Balance Sheet of Elixir Drugs Private Limited filed with the ROC?
The most recent Balance Sheet for Elixir Drugs Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
HK
Hemant KumarDirectorGT
Girish TyagiDirectorST
Savita TyagiDirector